Béland MA et al. |
Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study. |
2017 |
Transpl. Int. |
pmid:28186642
|
Sukkha S et al. |
Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study. |
2017 |
Int J Clin Pharm |
pmid:29101615
|
Song L et al. |
ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys. |
2017 |
Am. J. Transplant. |
pmid:27598231
|
Al-Uzri A et al. |
Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. |
2017 |
Pediatr Transplant |
pmid:28635157
|
Ekman-Joelsson BM et al. |
Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review. |
2017 |
Cardiol Young |
pmid:28780922
|
Saburi M et al. |
Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. |
2017 |
Int. J. Hematol. |
pmid:28516402
|
Ferreira A et al. |
Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. |
2017 |
Am. J. Nephrol. |
pmid:28511172
|
Ren S et al. |
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis. |
2017 |
PLoS ONE |
pmid:28898290
|
Piñana JL et al. |
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28396159
|
Wen Y et al. |
Inhibition of Calcineurin A by FK506 Suppresses Seizures and Reduces the Expression of GluN2B in Membrane Fraction. |
2017 |
Neurochem. Res. |
pmid:28299629
|
Forns X et al. |
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. |
2017 |
Transpl Infect Dis |
pmid:28295849
|
Lum EL et al. |
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma. |
2017 |
Am. J. Kidney Dis. |
pmid:28189378
|
Wang J et al. |
The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts. |
2017 |
Sci Rep |
pmid:28611384
|
Liu MZ et al. |
IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. |
2017 |
Acta Pharmacol. Sin. |
pmid:28112181
|
Herskovitz J et al. |
Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure. |
2017 |
AAPS J |
pmid:28070711
|
Noguchi A et al. |
Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice. |
2017 |
J. Dermatol. Sci. |
pmid:28069324
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Goldsmith PM et al. |
Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol. |
2017 |
BMJ Open |
pmid:28756385
|
Lewis DJ et al. |
Oral bexarotene for post-transplant cutaneous T-cell lymphoma. |
2017 |
Dermatol Ther |
pmid:28748653
|
Grinyó JM et al. |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27889299
|